143 related articles for article (PubMed ID: 9510313)
1. Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients.
Fu CG; Tominaga O; Nagawa H; Nita ME; Masaki T; Ishimaru G; Higuchi Y; Tsuruo T; Muto T
Dis Colon Rectum; 1998 Jan; 41(1):68-74. PubMed ID: 9510313
[TBL] [Abstract][Full Text] [Related]
2. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
Schwandner O; Bruch HP; Broll R
Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of p53, p21, and p27 expressions in rectal carcinoma.
Lebe B; Sarioğlu S; Sökmen S; Ellidokuz H; Füzün M; Küpelioğlu A
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):38-44. PubMed ID: 15722792
[TBL] [Abstract][Full Text] [Related]
4. p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas.
Marijnen CA; Kapiteijn E; Nagtegaal ID; Mulder-Stapel AA; van de Velde CJ; Schrier PI; Peltenburg LT; van Krieken JH
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):720-8. PubMed ID: 11849795
[TBL] [Abstract][Full Text] [Related]
5. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue.
Stift A; Prager G; Selzer E; Widder J; Kandioler D; Friedl J; Teleky B; Herbst F; Wrba F; Bergmann M
Int J Oncol; 2003 Nov; 23(5):1269-75. PubMed ID: 14532965
[TBL] [Abstract][Full Text] [Related]
6. The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma.
Palazzo JP; Kafka NJ; Grasso L; Chakrani F; Hanau C; Cuesta KH; Mercer WE
Hum Pathol; 1997 Oct; 28(10):1189-95. PubMed ID: 9343326
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the combination of molecular prognostic factors in tumor radiosensitivity in rectal cancer.
Komuro Y; Watanabe T; Tsurita G; Muto T; Nagawa H
Hepatogastroenterology; 2005; 52(63):666-71. PubMed ID: 15966178
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):897-902. PubMed ID: 12162767
[TBL] [Abstract][Full Text] [Related]
9. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
Pasz-Walczak G; Kordek R; Faflik M
Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890
[TBL] [Abstract][Full Text] [Related]
10. p53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein.
Backe J; Gassel AM; Hauber K; Krebs S; Bartek J; Caffier H; Kreipe HH; Müller-Hermelink HK; Dietl J
Int J Gynecol Pathol; 1997 Oct; 16(4):361-8. PubMed ID: 9421076
[TBL] [Abstract][Full Text] [Related]
11. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
[TBL] [Abstract][Full Text] [Related]
13. p21(Waf1/Cip1) and p53 protein expression in breast cancer.
Wakasugi E; Kobayashi T; Tamaki Y; Ito Y; Miyashiro I; Komoike Y; Takeda T; Shin E; Takatsuka Y; Kikkawa N; Monden T; Monden M
Am J Clin Pathol; 1997 Jun; 107(6):684-91. PubMed ID: 9169666
[TBL] [Abstract][Full Text] [Related]
14. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.
Lam KY; Lo CY; Chan KW; Wan KY
Ann Surg; 2000 Mar; 231(3):329-38. PubMed ID: 10714625
[TBL] [Abstract][Full Text] [Related]
15. p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2.
García JF; Piris MA; Lloret E; Orradre JL; Murillo PG; Martínez JC
Histopathology; 1997 Feb; 30(2):120-5. PubMed ID: 9067734
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
17. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome.
Graflund M; Sorbe B; Karlsson M
Int J Gynecol Cancer; 2002; 12(3):290-8. PubMed ID: 12060451
[TBL] [Abstract][Full Text] [Related]
19. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
Bukholm IK; Nesland JM
Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
[TBL] [Abstract][Full Text] [Related]
20. Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus.
Hanas JS; Lerner MR; Lightfoot SA; Raczkowski C; Kastens DJ; Brackett DJ; Postier RG
Cancer; 1999 Sep; 86(5):756-63. PubMed ID: 10463972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
